Metraipolis › archive › dc_07bb723700ca

Overcoming resistance barriers: Using the salvage therapy of Ceftazidime-Avibactam and Aztreonam for difficult-to-treat gram-negative infections at a tertiary… — Europe PMC PMID:42170395

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42170395
DOI
10.12669/pjms.42.(icon26).15693
License (as archived)
solo-consultazione
Archived
2026-11-03T13:42:34.537Z
SHA-256 of the archived text
51a0d050cfe9adbea3e4b88a73b118e8dec7d2d5518c66f2eb0a6d63a7e57d46
Stable URL of this page
https://metraipolis.com/documento/dc_07bb723700ca

How to cite

Overcoming resistance barriers: Using the salvage therapy of Ceftazidime-Avibactam and Aztreonam for difficult-to-treat gram-negative infections at a tertiary… — Europe PMC PMID:42170395 — Europe PMC (en), https://europepmc.org/article/MED/42170395 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07bb723700ca (Metraipolis archive dc_07bb723700ca, sha256 51a0d050cfe9adbea3e4b88a73b118e8dec7d2d5518c66f2eb0a6d63a7e57d46)
BibTeX
@misc{dc07bb723700ca,
  title = {Overcoming resistance barriers: Using the salvage therapy of Ceftazidime-Avibactam and Aztreonam for difficult-to-treat gram-negative infections at a tertiary… — Europe PMC PMID:42170395},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42170395},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07bb723700ca; sha256 51a0d050cfe9adbea3e4b88a73b118e8dec7d2d5518c66f2eb0a6d63a7e57d46},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42170395. Agents can read the archived copy with the MCP tool read_document.